Bellecapital International Ltd. lessened its holdings in shares of Cooper Companies Inc (NYSE:COO) by 4.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,357 shares of the medical device company’s stock after selling 489 shares during the quarter. Cooper Companies makes up 2.4% of Bellecapital International Ltd.’s investment portfolio, making the stock its 14th largest holding. Bellecapital International Ltd.’s holdings in Cooper Companies were worth $3,826,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Flagship Harbor Advisors LLC grew its position in Cooper Companies by 62.5% in the second quarter. Flagship Harbor Advisors LLC now owns 78 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 30 shares during the period. Evolution Wealth Advisors LLC bought a new stake in Cooper Companies in the second quarter valued at $34,000. Quadrant Capital Group LLC grew its holdings in shares of Cooper Companies by 827.8% during the first quarter. Quadrant Capital Group LLC now owns 167 shares of the medical device company’s stock worth $47,000 after purchasing an additional 149 shares during the last quarter. Zions Bancorporation N.A. bought a new stake in shares of Cooper Companies during the first quarter worth $53,000. Finally, CNB Bank bought a new stake in shares of Cooper Companies during the first quarter worth $59,000. 96.10% of the stock is currently owned by institutional investors.
COO has been the topic of several research analyst reports. Wells Fargo & Co increased their target price on Cooper Companies from $356.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Raymond James increased their target price on Cooper Companies from $325.00 to $364.00 and gave the company an “outperform” rating in a research note on Tuesday, July 2nd. Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $336.00 target price on the stock in a research note on Friday, June 7th. Piper Jaffray Companies increased their price target on Cooper Companies from $330.00 to $360.00 and gave the stock an “overweight” rating in a report on Tuesday. Finally, Northcoast Research restated a “buy” rating and issued a $340.00 price target (up from $331.00) on shares of Cooper Companies in a report on Monday, June 3rd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $322.91.
Shares of NYSE COO opened at $335.96 on Friday. The stock has a market capitalization of $16.83 billion, a PE ratio of 29.10, a P/E/G ratio of 2.58 and a beta of 0.90. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.21 and a quick ratio of 0.68. The business has a fifty day moving average price of $334.14 and a two-hundred day moving average price of $304.39. Cooper Companies Inc has a fifty-two week low of $228.65 and a fifty-two week high of $344.32.
Cooper Companies (NYSE:COO) last issued its quarterly earnings results on Thursday, May 30th. The medical device company reported $2.94 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.76 by $0.18. Cooper Companies had a return on equity of 17.25% and a net margin of 16.46%. The company had revenue of $654.30 million for the quarter, compared to analyst estimates of $655.00 million. During the same quarter last year, the company posted $2.86 EPS. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. On average, equities analysts expect that Cooper Companies Inc will post 12.28 EPS for the current year.
The firm also recently declared a Semi-Annual dividend, which was paid on Wednesday, August 7th. Stockholders of record on Tuesday, July 23rd were paid a $0.03 dividend. The ex-dividend date was Monday, July 22nd. Cooper Companies’s payout ratio is 0.52%.
Cooper Companies Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
See Also: Are sell-side analysts objective?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.